login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
BICYCLE THERAPEUTICS PLC-ADR (BCYC) Stock News
NASDAQ:BCYC -
US0887861088
-
ADR
7.1
USD
+0.01 (+0.14%)
Last: 8/22/2025, 8:00:02 PM
7.1
USD
0 (0%)
After Hours:
8/22/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BCYC Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Benzinga
4 Analysts Assess Bicycle Therapeutics: What You Need To Know
16 days ago - By: The Motley Fool
Bicycle (BCYC) Q2 Revenue Falls 69%
16 days ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
a month ago - By: Benzinga
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
2 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Bicycle Therapeutics
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
4 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Yahoo Finance
- Mentions:
GEHC
IDYA
CNTA
EWTX
...
Here's Why GE HealthCare Stock Sank in April
4 months ago - By: Yahoo Finance
- Mentions:
SKX
JANX
COGT
EWTX
...
State Street Report Shows Big Slump in April ETF Inflows
4 months ago - By: Yahoo Finance
- Mentions:
EVTL
EWTX
JANX
IDYA
...
Is Vertical Aerospace Ltd. (EVTL) the Best Small Cap Stock to Buy with the Biggest Upside Potential?
4 months ago - By: Yahoo Finance
- Mentions:
DHI
CMG
Is Bicycle Therapeutics plc (BCYC) the Best Small Cap Stock to Buy with the Biggest Upside Potential?
4 months ago - By: Yahoo Finance
- Mentions:
AMD
JANX
REXR
Chart of the Week: '10x Money Multiplier' for Bitcoin Could Take Wall Street by Storm
4 months ago - By: Yahoo Finance
- Mentions:
NFLX
ETSY
MSFT
C
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
4 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
4 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
5 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
5 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
6 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
7 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
7 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
8 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
8 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification
9 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts
9 months ago - By: Bicycle Therapeutics plc
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Please enable JavaScript to continue using this application.